News

Policy & Practice


 

The Fate of COX-2s

The first of several lawsuits against Merck, the manufacturer of the cyclooxygenase-2 inhibitor rofecoxib (Vioxx), got underway in Texas last month. More suits are expected to follow, including one brought by the Physicians Committee for Responsible Medicine which charges that Merck relied on animal tests showing that Vioxx was safe while ignoring mounting clinical evidence that the drug increased cardiac risks in people. Meanwhile, across the border in Canada, an expert panel convened by national health officials recommended last month that Vioxx be allowed back on the market. The panel also voted that celecoxib (Celebrex) should continue to be marketed in Canada and that valdecoxib (Bextra) should not be allowed back on the market. Celebrex is currently the only COX-2 inhibitor available in Canada. Merck voluntarily withdrew Vioxx from the market in 2004 in response to evidence that the drug increases the risk of cardiovascular events. Pfizer suspended sales of Bextra last year due to concerns about a serious skin disorder and short-term cardiovascular risk.

Rheumatologist Takes Helm

A rheumatologist is now heading the U.S. Bone & Joint Decade, a 10-year effort to raise awareness and improve treatment of musculoskeletal diseases. Nancy Lane, M.D., was elected to a 2-year term as president at the group's annual board meeting in June. Dr. Lane currently serves as the director of the Center for Healthy Aging and is a professor of medicine and rheumatology at the University of California, Davis. She is also the coeditor for the journal Arthritis & Rheumatism. Dr. Lane succeeds Regis O'Keefe, M.D., who served as president of the initiative since 2003. Dr. O'Keefe is a professor of orthopedics at the University of Rochester (N.Y.).

The Cost of Smoking Deaths

Smoking deaths cost the nation $92 billion in lost productivity on an annual basis, from 1997 to 2001, the Centers for Disease Control and Prevention reported. This reflects an increase of about $10 billion from the annual mortality losses for the years 1995 through 1999. During the same period, an estimated 438,000 premature deaths occurred each year as a result of smoking and exposure to secondhand smoke. To reduce the toll, “we must provide the 32 million smokers who say they want to quit with the tools and support to do it successfully,” CDC Director Julie Gerberding, M.D., said in a statement. In an independent action, the American Medical Association's House of Delegates took measures to discourage tobacco use at its annual meeting, voting to support increases in federal, state, and local excise taxes on tobacco. Such increases in the excise taxes should be used to fund the treatment of those afflicted by tobacco-related illness, and to support counter-advertising efforts, the resolution stated.

Health Insurance Statistics

The ranks of the uninsured appear to be leveling off, according to a survey conducted by the CDC's National Center for Health Statistics. In 2004, 42 million Americans of all ages were without health insurance, about the same level as in 1997, the first year this survey began tracking these statistics. In addition, one in five adults aged 18–64 years were without health insurance last year, a number that had been steadily rising in recent years, but also leveled off in 2004. The survey showed continued improvements in coverage for children: Seven million children aged under 18 years were without health insurance in 2004, compared with 10 million children in 1997.

Uneasy Retirement

Baby boomers are concerned about their financial and health security—and would favor setting aside a portion of their earnings in a special account to save for future medical expenses, a report from the Commonwealth Fund stated. In a nationally representative sample of 2,000 adults aged 50–70, very few thought they would have enough income and savings for retirement and three of five adults in this age group worry that they will not be able to afford medical care in the future. More than 50% of those working or with a working spouse said they would not have job-based retiree health benefits when they retire. These fears are somewhat warranted: 12 million older adults are currently uninsured or have had histories of unstable coverage. The survey reflected a strong interest among older adults in a Medicare health account that would allow people to add to savings as well as receive the traditional Medicare benefit.

NIH Extends Disclosure Deadline

Officials at the Department of Health and Human Services are giving employees at the National Institutes of Health more time to report prohibited financial interests and to divest stock. In its announcement of the extension, HHS wrote that the department is considering issuing revisions to its current ethics regulations. In February, the agency issued regulations prohibiting NIH employees from engaging in consulting relationships with organizations that are substantially affected by NIH decisions. And NIH employees who are required to file financial disclosure statements are prohibited from acquiring or holding financial interests, such as stocks, in these affected organizations. NIH employees now have until Oct. 3, 2005, to file financial disclosure reports and until Jan. 2, 2006, to divest of prohibited financial interests. This is the second extension offered to NIH employees. “There's no doubt in my mind that at the end of the day the advice that NIH gives has to be completely untainted, completely unimpeachable, and completely trusted,” NIH Director Elias Zerhouni, M.D., said during a teleconference sponsored by the Kaiser Family Foundation.

Recommended Reading

Avoiding Common Pitfalls of EHR Implementation
MDedge Rheumatology
Group Plans to Begin Certification Of EHR Products Later This Year
MDedge Rheumatology
Insurers Attempt to Crack Down on Imaging Costs
MDedge Rheumatology
Policy & Practice
MDedge Rheumatology
IOM Committee Begins Investigation of the FDA
MDedge Rheumatology
CMS Hospital Database to Drive Accountability : The effect of the new hospital database on the physician-patient relationship remains uncertain.
MDedge Rheumatology
National Medicare Policy on Kyphoplasty: Not Anytime Soon
MDedge Rheumatology
Tips for Assessing Malpractice Lawyers : Poor communication, neglect, and unclear billing policies top the list of complaints.
MDedge Rheumatology
Authorities Eye FNCS Practices for Potential Conflicts of Interest
MDedge Rheumatology
Aging Baby Boomers Could Sink Medical System
MDedge Rheumatology